Alekta Group

Alekta Group is a specialized Contract Research Organization (CRO) providing end-to-end clinical development and regulatory services to the global pharmaceutical and biotechnology industries. With a primary focus on Eastern Europe and the Commonwealth of Independent States (CIS), the company facilitates clinical trials from Phase I through Phase IV, ensuring compliance with local and international standards. Their service portfolio includes clinical monitoring, project management, pharmacovigilance, medical writing, and legal representation for foreign sponsors. Alekta Group is recognized for its expertise in navigating the unique regulatory landscapes of the Eurasian Economic Union (EAEU). The company supports a wide range of therapeutic areas, including oncology, cardiology, and neurology, by providing access to a diverse patient population and high-quality investigative sites. By offering tailored solutions for market access and post-marketing surveillance, Alekta Group serves as a strategic partner for companies looking to expand their footprint in the CIS region.